VERTEX PHARMACEUTICALS INC (1VRTX.MI) Earnings History & Surprises

BIT:1VRTX • US92532F1003

Current stock price

334.7 EUR
-2.05 (-0.61%)
Last:

1VRTX.MI Earnings overview

Past quarterly earnings results for VERTEX PHARMACEUTICALS INC (1VRTX.MI), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Nov 3, 2025
Period
Q3 / 2025
EPS Estimate
$4.72
Revenue Estimate
3.116B

Last Reported

Most Recent
Release Date
Aug 4, 2025
Period
Q2 / 2025
EPS Reported
$4.52
EPS Surprise
3.45%
Revenue Surprise
0.06%

Beat Rate

Last 8 Quarters
50%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q2 2025 4.52 4.37 3.45% 135.23% 2.965B 2.963B 0.06% 12.06%
Q1 2025 4.06 4.37 -7.20% -14.71% 2.77B 2.91B -4.80% 2.96%
Q4 2024 3.98 4.11 -3.07% -5.24% 2.912B 2.836B 2.68% 15.66%
Q3 2024 4.38 4.22 3.69% 7.35% 2.772B 2.778B -0.22% 11.61%
Q2 2024 -12.83 3.00 -527.57% -429.82% 2.646B 2.715B -2.56% 6.11%
Q1 2024 4.76 4.14 14.85% 56.07% 2.691B 2.63B 2.30% 13.30%
Q4 2023 4.20 4.18 0.36% 11.70% 2.518B 2.564B -1.81% 9.34%
Q3 2023 4.08 4.05 0.66% 1.75% 2.484B 2.55B -2.61% 6.39%
Q2 2023 3.89 3.96 -1.75% 8.06% 2.493B 2.468B 1.02% 13.52%
Q1 2023 3.05 3.06 -0.21% -13.35% 2.375B 2.384B -0.39% 13.22%
Q4 2022 3.76 3.58 4.95% 11.57% 2.303B 2.347B -1.89% 11.10%
Q3 2022 4.01 3.72 7.89% 12.64% 2.334B 2.271B 2.79% 17.65%
Q2 2022 3.60 3.55 1.44% 15.76% 2.196B 2.175B 0.97% 22.46%
Q1 2022 3.52 3.56 -1.18% 18.12% 2.098B 2.118B -0.97% 21.64%
Q4 2021 3.37 3.37 0.13% 34.26% 2.073B 2.043B 1.45% 27.32%
Q3 2021 3.56 3.14 13.27% 34.85% 1.984B 1.893B 4.82% 28.99%
Q2 2021 3.11 2.56 21.59% 19.16% 1.793B 1.752B 2.36% 17.64%
Q1 2021 2.98 2.74 8.66% 16.41% 1.724B 1.69B 2.03% 13.81%
Q4 2020 2.51 2.64 -5.00% - 1.628B 1.616B 0.73% -
Q3 2020 2.64 2.39 10.49% - 1.538B 1.515B 1.54% -
Q2 2020 2.61 2.12 23.38% - 1.524B 1.413B 7.89% -
Q1 2020 2.56 1.88 36.03% - 1.515B 1.313B 15.39% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

1VRTX.MI EPS Q2Q Growth1VRTX.MI EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 0 100 -100 -200 -300 -400

Revenue Historical Q2Q growth and Acceleration

1VRTX.MI Revenue Q2Q Growth1VRTX.MI Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 5 10 15 20 25

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
2
Average EPS beat (4)
-0.78%
Max EPS beat (4)
3.69%
Min EPS beat (4)
-7.20%

Revenue beat statistics

Revenue beat (4)
2
Average Revenue beat (4)
-0.57%
Max Revenue beat (4)
2.68%
Min Revenue beat (4)
-4.80%

Analysis

In the last 4 quarters, 1VRTX.MI has beaten EPS estimates in 2 out of 4 releases
1VRTX.MI has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, 1VRTX.MI reported -0.8% below the EPS estimates on average.
In the last 4 quarters, 1VRTX.MI reported -0.6% below the revenue estimates on average.
1VRTX.MI Overview 1VRTX.MI Technical Analysis Report 1VRTX.MI Fundamental Analysis Report 1VRTX.MI Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

VERTEX PHARMACEUTICALS INC / 1VRTX.MI Earnings FAQ

Can you provide the last earnings date for VERTEX PHARMACEUTICALS INC?

VERTEX PHARMACEUTICALS INC (1VRTX.MI) last reported earnings on 8/4/2025.

Did 1VRTX stock beat earnings estimates in the most recent quarter?

VERTEX PHARMACEUTICALS INC (1VRTX.MI) beat EPS estimates and beat revenue estimates in the most recent quarter.

How often does VERTEX PHARMACEUTICALS INC (1VRTX.MI) beat earnings estimates?

In the last 4 quarters, VERTEX PHARMACEUTICALS INC (1VRTX.MI) has beaten EPS estimates in 2 out of 4 releases.